FDA Drug Application (076491) for TRILYTE by MEDA PHARMS

Back to FDA Applications sponsored by MEDA PHARMS

Application Number076491
Product Number001
FormFOR SOLUTION;ORAL
Dosage420GM/BOT;1.48GM/BOT;5.72GM/BOT;11.2GM/BOT
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AA Products in conventional dosage forms not presenting bioequivalence problems
Reference Drug
Drug NameTRILYTE
Active IngredientPOLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE



Back to FDA Applications sponsored by MEDA PHARMS

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.